glp 1 melbourne A newly launched device in Australia is the first to be approved by the medical regulator to treat obesity. #weightloss #technology #goldcoast #melbourne | 7NEWS GLP-1 Spending Hit $5.8 Billion

They aim to make effective treatments affordable and accessible to everyone

Gender AS is more common in men than in women

These meds trick the body into thinking that it has more of the hormone than it actually does, which leads to increased amounts of insulin (which helps with insulin resistance)

Add in provider anonymity (zero out of 100 on licensed medical prescribers), pricing that is like pulling teeth to obtain, and a BBB C rating with 18 complaints, and theres a pattern of information that is harder to access than it should be

This causes an increase in glucose-dependent insulin secretion which results in a decrease in glucagon secretion (by stimulating the release of insulin and suppressing the release of glucagon, the body thinks it has enough insulin and the body will in return slow down glucagon production/release)

Medical justification for the prior authorization, outlining the necessity of the treatment